Tag Archives: James Tessmer

The VP, Finance & Accounting of Lexicon Pharmaceuticals (NASDAQ: LXRX) is Buying Shares

Yesterday, the VP, Finance & Accounting of Lexicon Pharmaceuticals (LXRX – Research Report), James Tessmer, bought shares of LXRX for $11.4K. Following this transaction James Tessmer’s holding in the company was increased by 29.97% to a total of $52.04K. In